Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2014

Feb 4, 2014

31982_dirs_2014-02-04_4ffa0c1d-c09c-405c-a6a0-77b1537b83d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2014-01-31

Reporting Person: Wilson Russell P (SVP, Business Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-31 Common Stock P 4900 $2.29 Acquired 54900 Direct

Footnotes

F1: Includes 4,900 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on January 31, 2014.